Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome

Sabine Duchatelet, Lia Crotti, Rachel A. Peat, Isabelle Denjoy, Hideki Itoh, Myriam Berthet, Seiko Ohno, Véronique Fressart, Maria Cristina Monti, Cristina Crocamo, Matteo Pedrazzini, Federica Dagradi, Alessandro Vicentini, Didier Klug, Paul A. Brink, Althea Goosen, Heikki Swan, Lauri Toivonen, Annukka M. Lahtinen, Kimmo KontulaWataru Shimizu, Minoru Horie, Alfred L. George, David Alexandre Trégouët, Pascale Guicheney, Peter J. Schwartz

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background-Long-QT syndrome (LQTS) is characterized by such striking clinical heterogeneity that, even among family members carrying the same mutation, clinical outcome can range between sudden death and no symptoms. We investigated the role of genetic variants as modifiers of risk for cardiac events in patients with LQTS. Methods and Results-In a matched case-control study including 112 patient duos with LQTS from France, Italy, and Japan, 25 polymorphisms were genotyped based on either their association with QTc duration in healthy populations or on their role in adrenergic responses. The duos were composed of 2 relatives harboring the same heterozygous KCNQ1 or KCNH2 mutation: 1 with cardiac events and 1 asymptomatic and untreated. The findings were then validated in 2 independent founder populations totaling 174 symptomatic and 162 asymptomatic patients with LQTS, and a metaanalysis was performed. The KCNQ1 rs2074238 T-allele was significantly associated with a decreased risk of symptoms 0.34 (0.19-0.61; P

Original languageEnglish
Pages (from-to)354-361
Number of pages8
JournalCirculation: Cardiovascular Genetics
Volume6
Issue number4
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Long QT Syndrome
Mutation
Sudden Death
Adrenergic Agents
Italy
Population
France
Case-Control Studies
Japan
Alleles

Keywords

  • Association studies
  • Genetics
  • Ion channel
  • Long-QT syndrome
  • Polymorphism
  • Risk factor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)
  • Genetics

Cite this

Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. / Duchatelet, Sabine; Crotti, Lia; Peat, Rachel A.; Denjoy, Isabelle; Itoh, Hideki; Berthet, Myriam; Ohno, Seiko; Fressart, Véronique; Monti, Maria Cristina; Crocamo, Cristina; Pedrazzini, Matteo; Dagradi, Federica; Vicentini, Alessandro; Klug, Didier; Brink, Paul A.; Goosen, Althea; Swan, Heikki; Toivonen, Lauri; Lahtinen, Annukka M.; Kontula, Kimmo; Shimizu, Wataru; Horie, Minoru; George, Alfred L.; Trégouët, David Alexandre; Guicheney, Pascale; Schwartz, Peter J.

In: Circulation: Cardiovascular Genetics, Vol. 6, No. 4, 08.2013, p. 354-361.

Research output: Contribution to journalArticle

Duchatelet, S, Crotti, L, Peat, RA, Denjoy, I, Itoh, H, Berthet, M, Ohno, S, Fressart, V, Monti, MC, Crocamo, C, Pedrazzini, M, Dagradi, F, Vicentini, A, Klug, D, Brink, PA, Goosen, A, Swan, H, Toivonen, L, Lahtinen, AM, Kontula, K, Shimizu, W, Horie, M, George, AL, Trégouët, DA, Guicheney, P & Schwartz, PJ 2013, 'Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome', Circulation: Cardiovascular Genetics, vol. 6, no. 4, pp. 354-361. https://doi.org/10.1161/CIRCGENETICS.113.000023
Duchatelet, Sabine ; Crotti, Lia ; Peat, Rachel A. ; Denjoy, Isabelle ; Itoh, Hideki ; Berthet, Myriam ; Ohno, Seiko ; Fressart, Véronique ; Monti, Maria Cristina ; Crocamo, Cristina ; Pedrazzini, Matteo ; Dagradi, Federica ; Vicentini, Alessandro ; Klug, Didier ; Brink, Paul A. ; Goosen, Althea ; Swan, Heikki ; Toivonen, Lauri ; Lahtinen, Annukka M. ; Kontula, Kimmo ; Shimizu, Wataru ; Horie, Minoru ; George, Alfred L. ; Trégouët, David Alexandre ; Guicheney, Pascale ; Schwartz, Peter J. / Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. In: Circulation: Cardiovascular Genetics. 2013 ; Vol. 6, No. 4. pp. 354-361.
@article{153eb15649a94824a46588eaca0c71cc,
title = "Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome",
abstract = "Background-Long-QT syndrome (LQTS) is characterized by such striking clinical heterogeneity that, even among family members carrying the same mutation, clinical outcome can range between sudden death and no symptoms. We investigated the role of genetic variants as modifiers of risk for cardiac events in patients with LQTS. Methods and Results-In a matched case-control study including 112 patient duos with LQTS from France, Italy, and Japan, 25 polymorphisms were genotyped based on either their association with QTc duration in healthy populations or on their role in adrenergic responses. The duos were composed of 2 relatives harboring the same heterozygous KCNQ1 or KCNH2 mutation: 1 with cardiac events and 1 asymptomatic and untreated. The findings were then validated in 2 independent founder populations totaling 174 symptomatic and 162 asymptomatic patients with LQTS, and a metaanalysis was performed. The KCNQ1 rs2074238 T-allele was significantly associated with a decreased risk of symptoms 0.34 (0.19-0.61; P",
keywords = "Association studies, Genetics, Ion channel, Long-QT syndrome, Polymorphism, Risk factor",
author = "Sabine Duchatelet and Lia Crotti and Peat, {Rachel A.} and Isabelle Denjoy and Hideki Itoh and Myriam Berthet and Seiko Ohno and V{\'e}ronique Fressart and Monti, {Maria Cristina} and Cristina Crocamo and Matteo Pedrazzini and Federica Dagradi and Alessandro Vicentini and Didier Klug and Brink, {Paul A.} and Althea Goosen and Heikki Swan and Lauri Toivonen and Lahtinen, {Annukka M.} and Kimmo Kontula and Wataru Shimizu and Minoru Horie and George, {Alfred L.} and Tr{\'e}gou{\"e}t, {David Alexandre} and Pascale Guicheney and Schwartz, {Peter J.}",
year = "2013",
month = "8",
doi = "10.1161/CIRCGENETICS.113.000023",
language = "English",
volume = "6",
pages = "354--361",
journal = "Circulation: Cardiovascular Genetics",
issn = "1942-3268",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome

AU - Duchatelet, Sabine

AU - Crotti, Lia

AU - Peat, Rachel A.

AU - Denjoy, Isabelle

AU - Itoh, Hideki

AU - Berthet, Myriam

AU - Ohno, Seiko

AU - Fressart, Véronique

AU - Monti, Maria Cristina

AU - Crocamo, Cristina

AU - Pedrazzini, Matteo

AU - Dagradi, Federica

AU - Vicentini, Alessandro

AU - Klug, Didier

AU - Brink, Paul A.

AU - Goosen, Althea

AU - Swan, Heikki

AU - Toivonen, Lauri

AU - Lahtinen, Annukka M.

AU - Kontula, Kimmo

AU - Shimizu, Wataru

AU - Horie, Minoru

AU - George, Alfred L.

AU - Trégouët, David Alexandre

AU - Guicheney, Pascale

AU - Schwartz, Peter J.

PY - 2013/8

Y1 - 2013/8

N2 - Background-Long-QT syndrome (LQTS) is characterized by such striking clinical heterogeneity that, even among family members carrying the same mutation, clinical outcome can range between sudden death and no symptoms. We investigated the role of genetic variants as modifiers of risk for cardiac events in patients with LQTS. Methods and Results-In a matched case-control study including 112 patient duos with LQTS from France, Italy, and Japan, 25 polymorphisms were genotyped based on either their association with QTc duration in healthy populations or on their role in adrenergic responses. The duos were composed of 2 relatives harboring the same heterozygous KCNQ1 or KCNH2 mutation: 1 with cardiac events and 1 asymptomatic and untreated. The findings were then validated in 2 independent founder populations totaling 174 symptomatic and 162 asymptomatic patients with LQTS, and a metaanalysis was performed. The KCNQ1 rs2074238 T-allele was significantly associated with a decreased risk of symptoms 0.34 (0.19-0.61; P

AB - Background-Long-QT syndrome (LQTS) is characterized by such striking clinical heterogeneity that, even among family members carrying the same mutation, clinical outcome can range between sudden death and no symptoms. We investigated the role of genetic variants as modifiers of risk for cardiac events in patients with LQTS. Methods and Results-In a matched case-control study including 112 patient duos with LQTS from France, Italy, and Japan, 25 polymorphisms were genotyped based on either their association with QTc duration in healthy populations or on their role in adrenergic responses. The duos were composed of 2 relatives harboring the same heterozygous KCNQ1 or KCNH2 mutation: 1 with cardiac events and 1 asymptomatic and untreated. The findings were then validated in 2 independent founder populations totaling 174 symptomatic and 162 asymptomatic patients with LQTS, and a metaanalysis was performed. The KCNQ1 rs2074238 T-allele was significantly associated with a decreased risk of symptoms 0.34 (0.19-0.61; P

KW - Association studies

KW - Genetics

KW - Ion channel

KW - Long-QT syndrome

KW - Polymorphism

KW - Risk factor

UR - http://www.scopus.com/inward/record.url?scp=84884514304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884514304&partnerID=8YFLogxK

U2 - 10.1161/CIRCGENETICS.113.000023

DO - 10.1161/CIRCGENETICS.113.000023

M3 - Article

C2 - 23856471

AN - SCOPUS:84884514304

VL - 6

SP - 354

EP - 361

JO - Circulation: Cardiovascular Genetics

JF - Circulation: Cardiovascular Genetics

SN - 1942-3268

IS - 4

ER -